Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
Syndax Pharmaceuticals logo in transparent PNG format
Syndax Pharmaceuticals Collaborates with Genentech to examine ...
Syndax Pharmaceuticals (SNDX) Stock Price, News & Analysis
Analyzing Syndax Pharmaceuticals (NASDAQ:SNDX) and Maze Therapeutics ...
Syndax Pharmaceuticals Nears Critical Regulatory Milestone - Stocks Today
Syndax Pharmaceuticals logo in transparent PNG and vectorized SVG formats
Syndax Pharmaceuticals - ASCO Annual 2024
Zevra Therapeutics Syndax Pharma Biotech Stocks
Syndax Pharmaceuticals on LinkedIn: #biotechnology
Syndax Pharmaceuticals, Inc. (SNDX) Stock Price, News, Quote & History ...
Syndax Pharmaceuticals (SNDX) Company Profile, History, Products & Services
Syndax Pharmaceuticals on LinkedIn: #biotech #jobs
Incyte and Syndax Receives US FDA Approval for Niktimvo (axatilimab ...
Syndax (SNDX) Stock Analysis: The Biotech with TWO Blockbuster Launches ...
Syndax Pharmaceuticals, Inc. (SNDX) Presents at 44th Annual J.P. Morgan ...
Syndax Announces U.S. FDA Breakthrough Therapy Designation Granted for ...
Syndax Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary
Syndax Pharmaceuticals is seeking smart, inspired, and forward-thinking ...
Syndax Pharmaceuticals Inc (SNDX) Q3 2025 Earnings Report Preview: What ...
Goldman Sachs Initiates Coverage of Syndax Pharmaceuticals (SNDX) with ...
Syndax Pharmaceuticals Hits Day Low at $13.03 Amid Price ...
Syndax Pharmaceuticals' Early Launch Success Signals Continued Growth ...
Syndax Pharmaceuticals on LinkedIn: Learn More About Syndax ...
Buy Syndax Pharmaceuticals Stock – SNDX Stock Quote Today & Investment ...
Syndax Pharmaceuticals Reports Fourth Quarter and Full Year 2022 ...
Join Us - Syndax | Syndax Pharmaceuticals
syndax treatment image
Syndax Gains Second FDA Approval for Revuforj in Acute Myeloid Leukemia ...
FDA approves Syndax drug revuforj for advanced leukemia | STAT
Congratulations Syndax Pharmaceuticals! We are proud to work with you ...
Careers - Syndax
Syndax Pharmaceuticals, Inc. (SNDX) SWOT Analysis – DCFmodeling.com
Syndax gets FDA okay for first-in-class leukaemia drug | pharmaphorum
Incyte und Syndax melden FDA-Zulassung von Niktimvo™ (Axatilimab-csfr ...
SYNDAX PHARMACEUTICALS: Announces FDA Clearance of IND Application for ...
Syndax Pharmaceuticals on LinkedIn: #biotech #careers #wearesyndax
Syndax Pharmaceuticals on LinkedIn: Thank you, BiotechTV!
Sending congratulations to the team at Syndax Pharmaceuticals on the ...
Syndax Q3 2025 slides: Strong product growth despite revenue miss, path ...
Syndax Pharma: Two Drug Launches Fuel Transformational Growth (NASDAQ ...
Syndax Launches Groundbreaking Revuforj for Leukemia Patients ...
Syndax Pharmaceuticals on LinkedIn: We are very proud to announce that ...
Syndax Q2 Earnings: 43% Revenue Growth, FDA Priority Review for Cancer ...
Syndax Pharmaceuticals (SNDX): Valuation in Focus After Revumenib Wins ...
Syndax Pharmaceuticals, Inc.
Syndax (SNDX) Gets FDA Priority Tag for Leukemia Drug NDA
Syndax - Etherio
Syndax Pharmaceuticals: Time to Buy or Sell?
Syndax Pharmaceuticals: A Dual-Driven Catalyst for Long-Term ...
Syndax Pharmaceuticals and Incyte Announce Axatilimab Phase 1/2 Data in ...
At Syndax Pharmaceuticals, we are reimagining how cancer is treated ...
Syndax Announces 23 ASH 2025 Abstracts, 6 Oral Presentations | SNDX ...
Syndax Pharmaceuticals' Relative Strength Upgrade: A Strategic Buying ...
Syndax Pharmaceuticals: The Story Brightens (NASDAQ:SNDX) | Seeking Alpha
Syndax Announces Positive Revuforj Data in Acute Leukemias from ...
Big Gain For Syndax Pharmaceuticals, Inc. | Stocktreats
Syndax Pharmaceuticals Issues New Inducement Grants Amidst Ongoing ...
Syndax Pharmaceuticals, Inc. (SNDX): This Small-Cap Healthcare Stock Is ...
Syndax Pharmaceuticals | LinkedIn
Syndax Pharmaceuticals on LinkedIn: Events & Presentations | Syndax ...
Syndax Pharmaceuticals, Inc.: Syndax Announces FDA Approval of Revuforj ...
Syndax Pharmaceuticals Salaries | Levels.fyi
Syndax (SNDX) Surges 40.5% in 3 Months • BioTech Health X
Home - Syndax
[10-Q] Syndax Pharmaceuticals, Inc. Quarterly Earnings Report | SNDX ...
Syndax Pharmaceuticals on LinkedIn: #happynewyear #biotech #careers
Syndax Pharmaceuticals on LinkedIn: #leukemias
Syndax Pharmaceuticals Achieves Third FDA Approval in 12 Months, Pivots ...
Working at Syndax Pharmaceuticals | Glassdoor
Syndax Pharmaceuticals names Daphne Karydas as new CFO | hrnxt.com
I am excited to announce that I will be joining Syndax Pharmaceuticals ...
Syndax Pharmaceuticals Inc Stock Price Today | NASDAQ: SNDX Live ...
Syndax Pharmaceuticals Stock Falls After Data From Mid-Stage Study Of ...
Syndax wins U.S. approval for leukemia treatment | Lampgen Clinical ...
Syndax and Nektar Announce Immuno-Oncology Clinical Trial Collaboration ...
Syndax wins U.S. approval for leukemia treatment | STAT
I am excited to announce that I have accepted an offer with Syndax ...
Syndax Pharmaceuticals on LinkedIn: #weflyhighertogether
Syndax Poised for Strong 2025 Report Amid Breakout Cancer Drug Sales ...
Syndax Pharmaceuticals Careers | Levels.fyi
Syndax Pharmaceuticals on LinkedIn: Revumenib Mechanism of Action (MOA)
Syndax Completes $115 Million Follow-On Offering | Baird
Syndax Pharmaceuticals Employee Perks & Benefits | Levels.fyi
临床阶段生物制药公司：Syndax Pharmaceuticals(SNDX) | 美股之家 - 港股美股开户投资百科全书
December 22 2021
SNDX Q2 2025 Earnings Report on 8/4/2025
超6亿美元！因赛特携手Syndax开发治疗慢性移植物抗宿主病和其他纤维化疾病的单抗疗法 药明康德 内容团队编辑9月27日，Syndax ...
SNDX Q1 2026 Earnings Report on 4/30/2026
SNDX (Syndax Pharmaceuticals, Inc.) – Technical Charts and Market Data ...
Acute Leukemia Drug Revuforj Wins FDA Approval, Second Approval for ...
FDA Approves Syndax's Revuforj® for Acute Leukemia with KMT2A Translocation
SNDX Q4 2025 Earnings Report on 2/26/2026
US FDA approves Syndax's blood cancer drug, ETPharma
Syndax’s Revuforj Receives FDA Priority Review in Acute Myeloid ...
FDA Approves Incyte/Syndax Partnered Drug For Chronic Graft-Versus-Host ...
Precision Medicine - CE Synergy | Oncology CE
臨牀階段生物制藥公司：Syndax Pharmaceuticals(SNDX) – 美股投資指南
Delos Capital | Finding, Funding and Fostering Global Innovation
Syndax-logo
Syndax, 특발성 폐 섬유증 신약후보물질 미FDA '희귀 의약품' 지정 대식세포를 타겟으로 하는 항체 신약후보물질 ...
หุ้น SNDX งบการเงิน 10 ปี พร้อมกราฟ - Finnomena
Life Science ERP Software | NetSuite
FLASCO / The Voice of Oncology in Florida
7 Health Care Stocks to Buy for Robust Returns | Kiplinger
Duality Biologics - 2026 Company Profile, Team, Funding & Competitors ...
Syndax制药简介-Syndax制药成立时间|总部|股票代码-排行榜123网
